Table 4
Clinical measurements of heart failure after placebo and statin administration
| Placebo | Statin treatment | p Value | |
|---|---|---|---|
| Data presented as mean (SEM). | |||
| MLHFQL, Minnesota Living with Heart Failure Quality of Life. | |||
| Internal dimension in diastole (mm) | 68.0 (2.5) | 67.0 (2.6) | 0.41 |
| Internal dimension in systole (mm) | 59.1 (2.7) | 56.6 (3.6) | 0.20 |
| Left ventricular ejection fraction (%) | 29.7 (2.3) | 31.0 (2.4) | 0.59 |
| Peak early diastolic transmitral flow velocity (cm/s) | 76.4 (7.6) | 76.8 (8.1) | 0.37 |
| Peak transmitral flow velocity with atrial contraction (cm/s) | 83.4 (4.8) | 76.6 (4.3) | 0.20 |
| Deceleration time (ms) | 224.5 (26.8) | 204.5 (18.3) | 0.37 |
| Left ventricular mass (g) | 273.9 (23.5) | 306.0 (32.1) | 0.25 |
| 6 min walking test (m) | 466.2 (18.9) | 471.9 (20.2) | 0.44 |
| MLHFQL questionnaire score | 28.5 (4.6) | 29.9 (4.5) | 0.63 |
